Devices/Safety Alert·openFDA/device

ENDOTAK RELIANCE (BOSTON SCIENTIFIC CORPORATION) — Malfunction

MediumPublished Sep 30, 2026· AI-analyzed Oct 13, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

A malfunction was reported involving the ENDOTAK RELIANCE device manufactured by Boston Scientific Corporation. The source documentation does not provide specific details regarding the nature or severity of the mechanical or electrical failure.

Who it affects

This report affects Boston Scientific Corporation and personnel responsible for the ENDOTAK RELIANCE product line, including Quality Assurance and Post-Market Surveillance teams monitoring cardiac lead performance.

Why it matters

The reporting of a malfunction for an implantable device necessitates professional scrutiny of the device's reliability and safety profile. While the source lacks specific failure mechanics, such reports typically trigger internal investigations to assess if the event rate exceeds established thresholds in the Risk Management File. This may lead to increased regulatory reporting requirements or a re-evaluation of the device's benefit-risk profile.

Practical takeaway

Regulatory and QA teams should review existing complaint data for the ENDOTAK RELIANCE product line to determine if this malfunction aligns with known failure modes or indicates a new trend. Ensure that post-market surveillance reports and Risk Management Files are updated to reflect the reported device performance.

FDA source material

Event type: Malfunction. Device: ENDOTAK RELIANCE by BOSTON SCIENTIFIC CORPORATION.

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.